RALEIGH, N.C., July 29, 2015 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization is a major sponsor and key participant in the Society for Clinical Research Sites (SCRS) Asia/Pacific Site Solutions Summit, taking place July 30-31, 2015, in Melbourne, Australia. Senior Vice President, Corporate Strategy Jean Chitwood will present "Collaborating for the Future: Developing Effective CRO, Site and Sponsor Relationships in a Changing Healthcare Environment" on Friday, July 31. Alan Ong, Executive Vice President, Asia/Pacific, will participate in an open dialogue with sites as part of the "To Tell the Truth Panel" with industry experts on Friday as well. In addition, INC is sponsoring a site appreciation reception Thursday evening to celebrate continued collaboration among key site stakeholders.
As part of INC's sponsorship of the Asia/Pacific summit, the company is awarding SCRS membership scholarships to all attending sites that are not currently society members. In 2014, INC Research became the first organization to support the SCRS' new member scholarship program as part of the Company's Circle of Sustainability sponsorship of the society. Through the scholarship program, INC Research supports the SCRS goal of expanding site membership to 5,000 sites. Following the Asia/Pacific summit, INC will have granted more than 175 SCRS membership scholarships to sites around the world.
"Asia/Pacific continues to grow in importance across the biopharmaceutical industry," said Alan Ong, Executive Vice President, Asia/Pacific. "Supporting and sustaining strong sites helps INC conduct vital research in a region that is home to almost 60 percent of the world's population. INC has been at the forefront of listening to and engaging with sites to provide tools and resources that increase efficiency, reduce financial burdens and improve performance. By actively participating in the SCRS Asia/Pacific summit, INC maintains and deepens relationships with clinical researchers."
INC Research continues to grow and enhance capabilities across Asia/Pacific, with 20 offices in key locations across the region, including a strong presence in Japan, China, India, Australia, Singapore, Philippines, South Korea, Taiwan, Hong Kong, Malaysia, Thailand, Indonesia and New Zealand. Having provided Phase I to IV clinical development services in the Asia/Pacific region for nearly 20 years, the Company has conducted more than 1,000 studies across a broad range of therapeutic areas.
About INC Research
INC Research (Nasdaq:INCR) is a leading global contract research organization (CRO) providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industry. Leveraging the breadth of our service offerings and the depth of our therapeutic expertise across multiple patient populations, INC Research connects customers, clinical research sites and patients to accelerate the delivery of new medicines to market. The Company was ranked "Top CRO to Work With" among large global CROs in the 2015 CenterWatch Global Investigative Site Relationship Survey. INC Research is headquartered in Raleigh, N.C., with operations across six continents and experience spanning more than 100 countries. For more information, please visit www.incresearch.com.
CONTACT: Investors: Ronnie Speight, +1 919 745 2745 Media: Lori Dorer, +1 513 345 1685Source:INC Research